intranasal spray
Showing 1 - 25 of 2,137
COVID-19 Prevention Trial in Louisville (Q-Griffithsin, Placebo)
Completed
- COVID-19 Prevention
- Q-Griffithsin
- Placebo
-
Louisville, KentuckyUniversity of Louisville
Apr 28, 2022
COVID-19 Prevention Trial in Louisville (Q-Griffithsin 3.0, Q-Griffithsin 6.0)
Recruiting
- COVID-19 Prevention
- Q-Griffithsin 3.0
- Q-Griffithsin 6.0
-
Louisville, KentuckyUniversity of Louisville Clinical Trials Unit
Jun 28, 2022
COVID-19 Trial in Yogyakarta, Kota Jkt Utara (AD17002 + Formulation buffer, Placebo)
Not yet recruiting
- COVID-19
- AD17002 + Formulation buffer
- Placebo
-
Yogyakarta, Daerah Istimewa Yogyakarta, Indonesia
- +2 more
Sep 13, 2022
Autism Spectrum Disorder, Bone Health Trial in Boston (1. Intranasal oxytocin spray, 2. Intranasal spray, 3. Intranasal
Not yet recruiting
- Autism Spectrum Disorder
- Bone Health
- 1. Intranasal oxytocin spray
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Feb 22, 2023
Allergic Rhinitis Trial in Kuala Lumpur (Rhinophototherapy, Nasonex Nasal Spray)
Not yet recruiting
- Allergic Rhinitis
- Rhinophototherapy
- Nasonex Nasal Spray
-
Kuala Lumpur, Cheras, MalaysiaOtorhinolaryngology Department, Head and Neck Surgery, Faculty o
Jun 25, 2023
Sleep Disorder; Breathing-Related, Snoring, Obstructive Sleep Apnea of Child Trial in Clayton, Parkville (Mometasone Furoate
Recruiting
- Sleep Disorder; Breathing-Related
- +5 more
- Mometasone Furoate 50mcg Nasal Spray
- Sodium Chloride 0.9 % Nasal Spray
-
Clayton, Victoria, Australia
- +1 more
Dec 19, 2022
Sleep Apnea, Obstructive Trial in Washington (Oxytocin Intranasal Spray, Placebo Intranasal Spray)
Completed
- Sleep Apnea, Obstructive
- Oxytocin Intranasal Spray
- Placebo Intranasal Spray
-
Washington, District of ColumbiaThe GW Medical Faculty Associates
Dec 2, 2021
Methamphetamine Use Disorder Trial in Richmond (Oxytocin nasal spray)
Not yet recruiting
- Methamphetamine Use Disorder
- Oxytocin nasal spray
-
Richmond, Victoria, AustraliaTurning Point
Mar 6, 2023
Covid19 Trial in Lenexa, Raleigh (Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 1, Single Dose, Intranasal
Recruiting
- Covid19
- Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 1, Single Dose, Intranasal Drops
- +4 more
-
Lenexa, Kansas
- +1 more
Aug 1, 2022
Allergic Rhinitis, Allergic Rhinitis Due to Grass Pollen, Healthy Volunteers Trial in Tustin, Mississauga (B244 suspension,
Completed
- Allergic Rhinitis
- +2 more
- B244 suspension
- Vehicle
-
Tustin, California
- +1 more
Oct 31, 2022
Healthy Subjects, Opioid Antagonist, Pharmacokinetics Trial in West Bend (Four naloxone nasal spray doses (1 every 2.5 min),
Completed
- Healthy Subjects
- +2 more
- Four naloxone nasal spray doses (1 every 2.5 min)
- +2 more
-
West Bend, WisconsinSpaulding Clinical Research
Mar 17, 2022
Snoring, Mouth Breathing Trial in Changsha (Nebulized Budesonide, Intranasal Budesonide Spray)
Not yet recruiting
- Snoring
- Mouth Breathing
- Nebulized Budesonide
- Intranasal Budesonide Spray
-
Changsha, Hunan, ChinaDepartment of Otolaryngology, Second Xiangya Hospital, Central S
Apr 16, 2022
Allergic Rhinitis Trial in Beijing (PA9159 nasal spray solution, 10 µg one day treatment, PA9159 nasal spray solution, 20 µg one
Completed
- Allergic Rhinitis
- PA9159 nasal spray solution, 10 μg one day treatment
- +6 more
-
Beijing, Beijing, ChinaBeijing TongRen Hospital
Jan 4, 2022
Deep Sedation Trial in Stockholm (Dexmedetomidine)
Completed
- Deep Sedation
-
Stockholm, SwedenKarolinska University Hospital
Dec 13, 2021
Tinnitus Trial in New York (Oxytocin, Placebo nasal spray)
Terminated
- Tinnitus
- Oxytocin
- Placebo nasal spray
-
New York, New York222 East 41st Street Ambulatory Care Center, Preston Robert Tisc
Sep 7, 2022
Ketamine Treatment Trial in Vienna (56mg esketamine (2x Spravato® 28 mg nasal spray), 0.9% saline solution nasal spray)
Recruiting
- Ketamine Treatment
- 56mg esketamine (2x Spravato® 28 mg nasal spray)
- 0.9% saline solution nasal spray
-
Vienna, AustriaDepartment of Psychiatry and Psychotherapy
Jul 14, 2022
Central Diabetes Insipidus (cDI) Trial in Basel (Intranasal OXT, Placebo nasal spray)
Not yet recruiting
- Central Diabetes Insipidus (cDI)
- Intranasal OXT
- Placebo nasal spray
-
Basel, SwitzerlandUniversity Hospital Basel, Department of Endocrinology, Diabetes
Sep 6, 2023
Obesity Trial in Boston (oxytocin nasal spray, Placebo)
Completed
- Obesity
- oxytocin nasal spray
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Aug 23, 2022
Effect of Drug Trial in Karachi (Lidocaine topical, Lidocaine Hydrochloride)
Completed
- Effect of Drug
- Lidocaine topical
- Lidocaine Hydrochloride
-
Karachi, Sindh, PakistanDow University of Health Sciences
Jan 26, 2021
Antisocial Personality Disorder Trial in London (Oxytocin nasal spray, Placebo spray)
Completed
- Antisocial Personality Disorder
- Oxytocin nasal spray
- Placebo spray
-
London, Nottinghamshire, United KingdomInsititue of Psychiarty, Psychology and Neuroscience
May 16, 2022
Autism Spectrum Disorder Trial in Oslo (Oxytocin nasal spray, Placebo)
Not yet recruiting
- Autism Spectrum Disorder
- Oxytocin nasal spray
- Placebo
-
Oslo, NorwayUllevål Hospital
Jul 6, 2023
Rhinosinusitis Trial in Thái Bình (0.9% NaCl isotonic saline solution, Bacillus subtilis DSM32444, inactivated)
Completed
- Rhinosinusitis
- 0.9% NaCl isotonic saline solution
- Bacillus subtilis DSM32444, inactivated
-
Thái Bình, Thai Binh, VietnamThai Binh University of Medicine and Pharmacy
Aug 8, 2023
MDD Trial in Toronto (Humalog, Saline nasal spray)
Recruiting
- Major Depressive Disorder
- Humalog
- Saline nasal spray
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Oct 5, 2022